Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 170.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.061%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 170.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Dec 2017 15:35

RNS Number : 4158Z
Helios Underwriting Plc
14 December 2017
 

Helios Underwriting plc ("Helios" or the "Company")

Director/PDMR Shareholding

Ordinary Shares issued under the Company's Joint Share Ownership Plan ("JSOP")

Helios announces that, on 14th December 2017, it issued and allotted 500,000 new ordinary shares of £0.10 each ("Ordinary Shares"). The new Ordinary Shares have been issued at a subscription price of 133.5p per Ordinary Share, being the closing price of an Ordinary Share on 13th December 2017, pursuant to The Helios Underwriting plc Employees' Joint Share Ownership Plan (the "Plan").

The new Ordinary Shares have been issued into the respective joint beneficial ownership of (i) each of the participating executive Directors listed below and (ii) the trustee of the Trust upon and subject to the terms of joint ownership agreements ("JOAs") respectively entered into between the Director, the Company and the Trustee. The nominal value of the new Ordinary Shares has been paid by the Trust out of funds advanced to it by the Company with the additional consideration of 123.5p left outstanding until such time as new Ordinary Shares are sold. The Company has waived its lien on the Shares such that there are no restrictions on their transfer.

The terms of the JOAs provide, inter alia, that if jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners so that the participating Director receives an amount equal to any growth in the market value of the jointly owned Ordinary Shares above the greater of either:

a) the initial market value (133.5p per share), less a "carrying cost" (equivalent to simple interest at 4.5 per cent per annum on the initial market value accruing over the three years from the date of award) and the Trust receives the initial market value of the jointly owned shares plus the carrying cost; or

 

b) if higher, 150p (so that the participating Director will only ever receive value if the share sale price exceeds this).

The vesting of the award will be subject to performance conditions measured over the three calendar years from the award date.

Note:

The Plan was established and approved by resolution of the Remuneration Committee of the Company on 13 December 2017 and provides for the acquisition by employees, including executive directors, of beneficial interests as joint owners (with the Trust) of Ordinary Shares in the Company upon the terms of a JOA. The terms of the JOA provide that if the jointly owned shares become vested and are sold, the proceeds of sale will be divided between the joint owners on the terms set out above.

Effect of the transactions

The beneficial interests of the executives following the transaction will be as follows:

Director

Interests in jointly owned Ordinary Shares issued under JSOP

Other interests in Ordinary Shares

Total Shareholding

Arthur Manners

200,000

133,334

333,334

Nigel Hanbury

300,000

2,436,871

2,736,871

 

Application for Admission of Ordinary Shares and total Voting Rights

Application has been made for the admission to trading on AIM ("Admission") of the 500,000 new Ordinary Shares, and it is expected that Admission will be effective on 20 December 2017.

The new Ordinary Shares will rank pari passu with the Company's existing issued Ordinary Shares. The Company's issued share capital following Admission will comprise 15,104,240 Ordinary Shares with voting rights and no restrictions on transfer and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

For further information please contact:

Helios Underwriting plc

Nigel Hanbury - Chief Executive 020 7863 6655 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

 

Stockdale Securities Limited

Robert Finlay 020 7601 6100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEZLFFDLFXFBX
Date   Source Headline
2nd Oct 20237:00 amRNSTotal Voting Rights
28th Sep 20237:00 amRNSHalf Year Results
11th Sep 202311:46 amRNSTransaction in Own Shares
8th Sep 202310:23 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20233:27 pmRNSTransaction in Own Shares
4th Sep 20233:36 pmRNSTransaction in Own Shares
1st Sep 202311:06 amRNSTransaction in Own Shares
1st Sep 20237:00 amRNSTotal Voting Rights
31st Aug 202311:05 amRNSTransaction in Own Shares
30th Aug 20234:05 pmRNSTransaction in Own Shares
30th Aug 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
29th Aug 202312:30 pmRNSTransaction in Own Shares
25th Aug 20232:12 pmRNSTransaction in Own Shares
25th Aug 20237:00 amRNSTransaction in Own Shares
24th Aug 20237:00 amRNSTransaction in own shares
23rd Aug 202311:44 amRNSShare Repurchase Programme
21st Aug 20234:23 pmRNSNotification of Major Holdings
21st Aug 202311:40 amRNSDirector's Shareholding
18th Aug 20238:22 amRNSTransaction in Own Shares
17th Aug 20237:00 amRNSTransaction in Own Shares
15th Aug 20234:30 pmRNSShare Repurchase Programme
2nd Aug 20237:00 amRNSTotal Voting Rights
25th Jul 20237:00 amRNSAcquisition
14th Jul 20237:00 amRNSDirector Dealing
14th Jul 20237:00 amRNSAcquisition of Limited Liability Vehicle
13th Jul 20237:00 amRNSIssue of Equity
4th Jul 20237:00 amRNSResults of Scrip Dividend Election
29th Jun 20233:46 pmRNSDirectorship Change
29th Jun 202311:27 amRNSResults of Annual General Meeting
29th Jun 20237:00 amRNSNotification of Major Holdings
16th Jun 20237:00 amRNSScrip Dividend Reference Price
7th Jun 20233:53 pmRNSDirector’s Shareholding
5th Jun 20233:39 pmRNSFinal Dividend Timetable
5th Jun 20237:00 amRNSDirector’s/PCA Shareholdings
1st Jun 20237:00 amRNSGrant of LTIP Award
31st May 20237:00 amRNSQuarterly Syndicate Mid-Point Forecasts
31st May 20237:00 amRNSPosting of Annual Report and Notice of AGM
26th May 20237:00 amRNSFinal Results
12th May 20237:00 amRNSChange of Adviser
11th May 20237:00 amRNSDirectors' Disclosure
11th Apr 20237:00 amRNSDirector's/PCAs' Shareholding
5th Apr 20237:00 amRNSGrant of LTIP Award and Director Dealing
5th Apr 20237:00 amRNSDirector/PCA Shareholdings
4th Apr 20237:00 amRNSDirectorate Change
4th Apr 20237:00 amRNSQuarterly Syndicate Mid Point Forecasts
10th Jan 20237:00 amRNS2023 Helios Retained Capacity Update
29th Dec 20223:38 pmRNSAcquisitions of LLVs, Issue of Equity and TVR
20th Dec 20227:00 amRNSHolding(s) in Company
19th Dec 202212:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.